A combination of immunohistochemistry and molecular approaches improves highly sensitive detection of BRAF mutations in papillary thyroid cancer

作者: Claudia Martinuzzi , Lorenza Pastorino , Virginia Andreotti , Anna Garuti , Michele Minuto

DOI: 10.1007/S12020-015-0720-9

关键词:

摘要: The optimal method for BRAF mutation detection remains to be determined despite advances in molecular techniques. aim of this study was compare, against classical Sanger sequencing, the diagnostic performance two most recently developed, highly sensitive methods: V600E immunohistochemistry (IHC) and peptide nucleic-acid (PNA)-clamp qPCR. exon 15 mutations were searched formalin-fixed paraffin-embedded tissues from 86 papillary thyroid carcinoma using three methods. limits sequencing borderline or discordant cases quantified by next generation sequencing. found 74.4 % PNA, 71 % IHC, 64 % Complete concordance methods observed 80 % samples. Better with combination methods, particularly PNA IHC (59/64) (92 %), while concordant 55 (86 %). Sensitivity 99 % 94.2 % 89.5 % Sanger. Our data show that could used as a cost-effective, first-line daily practice, followed analysis negative uninterpretable cases, efficient method. PNA-clamp quantitative PCR is complementary it also recognizes other besides suitable purposes.

参考文章(54)
Daniëlle A.M. Heideman, Irene Lurkin, Marije Doeleman, Egbert F. Smit, Henk M. Verheul, Gerrit A. Meijer, Peter J.F. Snijders, Erik Thunnissen, Ellen C. Zwarthoff, KRAS and BRAF Mutation Analysis in Routine Molecular Diagnostics: Comparison of Three Testing Methods on Formalin-Fixed, Paraffin-Embedded Tumor-Derived DNA The Journal of Molecular Diagnostics. ,vol. 14, pp. 247- 255 ,(2012) , 10.1016/J.JMOLDX.2012.01.011
Marco Russo, Pasqualino Malandrino, Maria Luisa Nicolosi, Mario Manusia, Ilenia Marturano, Maria Antonietta Trovato, Gabriella Pellegriti, Francesco Frasca, Riccardo Vigneri, The BRAF(V600E) mutation influences the short- and medium-term outcomes of classic papillary thyroid cancer, but is not an independent predictor of unfavorable outcome. Thyroid. ,vol. 24, pp. 1267- 1274 ,(2014) , 10.1089/THY.2013.0675
Francesco Spagnolo, Paola Ghiorzo, Paola Queirolo, Overcoming resistance to BRAF inhibition in BRAF-mutated metastatic melanoma. Oncotarget. ,vol. 5, pp. 10206- 10221 ,(2014) , 10.18632/ONCOTARGET.2602
Esther Diana Rossi, Maurizio Martini, Sara Capodimonti, Tonia Cenci, Patrizia Straccia, Basilio Angrisani, Costantino Ricci, Paola Lanza, Celestino Pio Lombardi, Alfredo Pontecorvi, Luigi Maria Larocca, Guido Fadda, Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: a cytohistologic institutional experience. Cancer Cytopathology. ,vol. 122, pp. 527- 535 ,(2014) , 10.1002/CNCY.21416
Michelle V. Pearlstein, Daniel C. Zedek, David W. Ollila, Amanda Treece, Margaret L. Gulley, Pamela A. Groben, Nancy E. Thomas, Validation of the VE1 immunostain for the BRAF V600E mutation in melanoma. Journal of Cutaneous Pathology. ,vol. 41, pp. 724- 732 ,(2014) , 10.1111/CUP.12364
Salih Ibrahem, Rashmi Seth, Brendan O’Sullivan, Wakkas Fadhil, Philippe Taniere, Mohammad Ilyas, Comparative analysis of pyrosequencing and QMC-PCR in conjunction with high resolution melting for KRAS/BRAF mutation detection. International Journal of Experimental Pathology. ,vol. 91, pp. 500- 505 ,(2010) , 10.1111/J.1365-2613.2010.00733.X
Frank A. Sinicrope, Thomas C. Smyrk, David Tougeron, Stephen N. Thibodeau, Shalini Singh, Andrea Muranyi, Kandavel Shanmugam, Thomas M. Grogan, Steven R. Alberts, Qian Shi, Mutation-specific antibody detects mutant BRAFV600Eprotein expression in human colon carcinomas Cancer. ,vol. 119, pp. 2765- 2770 ,(2013) , 10.1002/CNCR.28133
Anne-Katrin Zimmermann, Ulrike Camenisch, Markus P. Rechsteiner, Beata Bode-Lesniewska, Matthias Rössle, Value of immunohistochemistry in the detection of BRAFV600E mutations in fine‐needle aspiration biopsies of papillary thyroid carcinoma Cancer Cytopathology. ,vol. 122, pp. 48- 58 ,(2014) , 10.1002/CNCY.21352
Marius I. Ilie, Sandra Lassalle, Elodie Long-Mira, Christelle Bonnetaud, Olivier Bordone, Virginie Lespinet, Aude Lamy, Jean-Christophe Sabourin, Juliette Haudebourg, Catherine Butori, Nicolas Guevara, Isabelle Peyrottes, Jean-Louis Sadoul, Alexandre Bozec, José Santini, David Capper, Andreas von Deimling, Jean-François Emile, Véronique Hofman, Paul Hofman, Diagnostic value of immunohistochemistry for the detection of the BRAF(V600E) mutation in papillary thyroid carcinoma: comparative analysis with three DNA-based assays. Thyroid. ,vol. 24, pp. 858- 866 ,(2014) , 10.1089/THY.2013.0302
Yasuhiro Ito, Takashi Uruno, Yuuki Takamura, Akihiro Miya, Kaoru Kobayashi, Fumio Matsuzuka, Kanji Kuma, Akira Miyauchi, Papillary microcarcinomas of the thyroid with preoperatively detectable lymph node metastasis show significantly higher aggressive characteristics on immunohistochemical examination. Oncology. ,vol. 68, pp. 87- 96 ,(2005) , 10.1159/000085701